Our opinion on the current state of GLI

Go Life International (GLI) is a company listed in Mauritius with a secondary listing on the JSE's Alt-X market. Its focus is in "nutraceuticals" which are products associated with alternative medicine. In other words, they are not pharmaceuticals directly, but claim to offer consumers health benefits. The company was formed to acquire and exploit companies in South Africa which produce nutraceuticals. The company currently owns Go Life Health Products and Gotha Health Products. In their results for the year to 28th February 2023 the company reported no revenue and a headline loss per share of US$0,00012 compared with a loss of US$0,00007 in the previous year. They continuously delayed the publication of their financials. Until they can generate revenue and increase the free float and tradability of their shares, we do not believe that they are a practical investment for private investors. On 6th November 2023 the company's board announced that it will propose to change the company's name to "Numeral Limited".
Technical IndicatorsTrend Analysis

גם על:

כתב ויתור